While Lyn rarely appears as an initiator of leukaemogenesis, mounting evidence implicates it in playing a role in maintaining the leukemic phenotype in a variety of liquid cancers, including AML, CML, B-ALL and B-CLL. Here, LYN is linked to chronic myelogenous leukemia, BCR-ABL1 positive.